1+ day, 13+ hour ago   (343+ words) FUJIFILM India has installed and commissioned its Echelon Smart MRI at JANSONS HEALTH in Erode, Tamil Nadu, expanding access to advanced MRI diagnostics beyond major urban centres. The installation marks a significant milestone for FUJIFILM India as the company’s first…...

4+ day, 10+ hour ago   (367+ words) Kaisha Pharma has established Kaisha Pharma International in Italy as its global business development and customer support hub. The move marks latest step in the company’s strategy to build an international pharmaceutical packaging business. Based in Italy, Kaisha Pharma International…...

5+ day, 5+ hour ago   (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...

5+ day, 23+ hour ago   (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...

6+ day, 12+ hour ago   (65+ words) India continued to account for the majority of Molbio's business, contributing 83.52% of revenue, while exports accounted for 16.48% Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to…...

1+ week, 4+ hour ago   (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...

1+ week, 11+ hour ago   (289+ words) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) has announced an H-share repurchase plan of up to HK$1 billion, with the repurchased shares to be either cancelled or held as treasury shares. The company said the programme has come into…...

1+ week, 5+ day ago   (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...

1+ week, 6+ day ago   (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...

1+ week, 6+ day ago   (69+ words) The agreement recognizes Sun Pharma’s investment in the US market by delaying Section 232 tariffs on innovative pharmaceutical products for more than two years Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push…...